Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance

降低抗生素耐药性风险的针对性临床试验

• 批准号: 9004364
• 负责人: ALEHANDRO HOBERMAN
• 金额: $ 94.15万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-24 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9004364
• 关键词: Antibiotics; Antimicrobial Resistance; Childhood; Clinical Trials; Drug Exposure; Drug resistance; Pneumonia; Population; Probability; Regimen; Risk; design; safety testing; therapeutic effectiveness

To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.

评估测试治疗方法/方案的安全性和有效性的策略，以最大限度地减少不必要的药物暴露，以减少出现抗生素耐药性的可能性。